Literature DB >> 33394006

Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19.

Orestis A Panagiotou1,2,3, Cyrus M Kosar1,2, Elizabeth M White1,2, Leonidas E Bantis4, Xiaofei Yang2, Christopher M Santostefano2, Richard A Feifer5,6, Carolyn Blackman5,6, James L Rudolph1,2,3, Stefan Gravenstein1,2,3,7, Vincent Mor1,2,3.   

Abstract

Importance: The coronavirus disease 2019 (COVID-19) pandemic has severely affected nursing homes. Vulnerable nursing home residents are at high risk for adverse outcomes, but improved understanding is needed to identify risk factors for mortality among nursing home residents. Objective: To identify risk factors for 30-day all-cause mortality among US nursing home residents with COVID-19. Design, Setting, and Participants: This cohort study was conducted at 351 US nursing homes among 5256 nursing home residents with COVID-19-related symptoms who had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection confirmed by polymerase chain reaction testing between March 16 and September 15, 2020. Exposures: Resident-level characteristics, including age, sex, race/ethnicity, symptoms, chronic conditions, and physical and cognitive function. Main Outcomes and Measures: Death due to any cause within 30 days of the first positive SARS-CoV-2 test result.
Results: The study included 5256 nursing home residents (3185 women [61%]; median age, 79 years [interquartile range, 69-88 years]; and 3741 White residents [71%], 909 Black residents [17%], and 586 individuals of other races/ethnicities [11%]) with COVID-19. Compared with residents aged 75 to 79 years, the odds of death were 1.46 (95% CI, 1.14-1.86) times higher for residents aged 80 to 84 years, 1.59 (95% CI, 1.25-2.03) times higher for residents aged 85 to 89 years, and 2.14 (95% CI, 1.70-2.69) times higher for residents aged 90 years or older. Women had lower risk for 30-day mortality than men (odds ratio [OR], 0.69 [95% CI, 0.60-0.80]). Two comorbidities were associated with mortality: diabetes (OR, 1.21 [95% CI, 1.05-1.40]) and chronic kidney disease (OR, 1.33 [95%, 1.11-1.61]). Fever (OR, 1.66 [95% CI, 1.41-1.96]), shortness of breath (OR, 2.52 [95% CI, 2.00-3.16]), tachycardia (OR, 1.31 [95% CI, 1.04-1.64]), and hypoxia (OR, 2.05 [95% CI, 1.68-2.50]) were also associated with increased risk of 30-day mortality. Compared with cognitively intact residents, the odds of death among residents with moderate cognitive impairment were 2.09 (95% CI, 1.68-2.59) times higher, and the odds of death among residents with severe cognitive impairment were 2.79 (95% CI, 2.14-3.66) times higher. Compared with residents with no or limited impairment in physical function, the odds of death among residents with moderate impairment were 1.49 (95% CI, 1.18-1.88) times higher, and the odds of death among residents with severe impairment were 1.64 (95% CI, 1.30-2.08) times higher. Conclusions and Relevance: In this cohort study of US nursing home residents with COVID-19, increased age, male sex, and impaired cognitive and physical function were independently associated with mortality. Understanding these risk factors can aid in the development of clinical prediction models of mortality in this population.

Entities:  

Mesh:

Year:  2021        PMID: 33394006      PMCID: PMC7783593          DOI: 10.1001/jamainternmed.2020.7968

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  59 in total

1.  COVID-19 Mortality Rates Among Nursing Home Residents Declined From March To November 2020.

Authors:  Cyrus M Kosar; Elizabeth M White; Richard A Feifer; Carolyn Blackman; Stefan Gravenstein; Orestis A Panagiotou; Kevin McConeghy; Vincent Mor
Journal:  Health Aff (Millwood)       Date:  2021-03-11       Impact factor: 6.301

2.  Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.

Authors:  Lin Liu; Shu-Yu Ni; Wei Yan; Qing-Dong Lu; Yi-Miao Zhao; Ying-Ying Xu; Huan Mei; Le Shi; Kai Yuan; Ying Han; Jia-Hui Deng; Yan-Kun Sun; Shi-Qiu Meng; Zheng-Dong Jiang; Na Zeng; Jian-Yu Que; Yong-Bo Zheng; Bei-Ni Yang; Yi-Miao Gong; Arun V Ravindran; Thomas Kosten; Yun Kwok Wing; Xiang-Dong Tang; Jun-Liang Yuan; Ping Wu; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  EClinicalMedicine       Date:  2021-09-08

3.  Association of Healthcare Access With Intensive Care Unit Utilization and Mortality in Patients of Hispanic Ethnicity Hospitalized With COVID-19.

Authors:  Ferdinand Velasco; Donghan M Yang; Minzhe Zhang; Tanna Nelson; Thomas Sheffield; Tony Keller; Yiqing Wang; Clark Walker; Chaitanya Katterapalli; Kelli Zimmerman; Andrew Masica; Christoph U Lehmann; Yang Xie; John W Hollingsworth
Journal:  J Hosp Med       Date:  2021-11       Impact factor: 2.960

4.  Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.

Authors:  Hans-Georg Rammensee; Cécile Gouttefangeas; Sonja Heidu; Reinhild Klein; Beate Preuß; Juliane Sarah Walz; Annika Nelde; Sebastian P Haen; Michael Reth; Jianying Yang; Ghazaleh Tabatabai; Hans Bösmüller; Helen Hoffmann; Michael Schindler; Oliver Planz; Karl-Heinz Wiesmüller; Markus W Löffler
Journal:  Vaccines (Basel)       Date:  2021-04-24

5.  The association of nursing home quality ratings and spread of COVID-19.

Authors:  Christianna S Williams; Qing Zheng; Alan J White; Ariana I Bengtsson; Evan T Shulman; Kurt R Herzer; Lee A Fleisher
Journal:  J Am Geriatr Soc       Date:  2021-06-07       Impact factor: 7.538

6.  Short-term impact of nursing home SARS-CoV-2 vaccinations on new infections, hospitalizations, and deaths.

Authors:  Vincent Mor; Roee Gutman; Xiaofei Yang; Elizabeth M White; Kevin W McConeghy; Richard A Feifer; Carolyn R Blackman; Cyrus M Kosar; Barbara H Bardenheier; Stefan A Gravenstein
Journal:  J Am Geriatr Soc       Date:  2021-04-16       Impact factor: 7.538

7.  Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines.

Authors:  Reid McMurry; Patrick Lenehan; Samir Awasthi; Eli Silvert; Arjun Puranik; Colin Pawlowski; A J Venkatakrishnan; Praveen Anand; Vineet Agarwal; John C O'Horo; Gregory J Gores; Amy W Williams; Andrew D Badley; John Halamka; Abinash Virk; Melanie D Swift; Katie Carlson; Deeksha Doddahonnaiah; Anna Metzger; Nikhil Kayal; Gabi Berner; Eshwan Ramudu; Corinne Carpenter; Tyler Wagner; Ajit Rajasekharan; Venky Soundararajan
Journal:  Med (N Y)       Date:  2021-07-01

8.  Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening.

Authors:  David A Nace; Kevin E Kip; John W Mellors; Octavia M Peck Palmer; Michael R Shurin; Katie Mulvey; Melissa Crandall; Michele D Sobolewski; P Nathan Enick; Kevin D McCormic; Jana L Jacobs; April L Kane; Amy Lukanski; Paula L Kip; Alan Wells
Journal:  J Am Med Dir Assoc       Date:  2021-06-12       Impact factor: 4.669

9.  Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.

Authors:  Marcel Ballin; Jonathan Bergman; Miia Kivipelto; Anna Nordström; Peter Nordström
Journal:  J Am Med Dir Assoc       Date:  2021-06-24       Impact factor: 4.669

10.  Estimation of Excess Mortality Rates Among US Assisted Living Residents During the COVID-19 Pandemic.

Authors:  Kali S Thomas; Wenhan Zhang; David M Dosa; Paula Carder; Philip Sloane; Sheryl Zimmerman
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.